市場調查報告書

失眠症治療藥市場分析:治療類別(設備,藥物:苯重氮基鹽,非苯重氮基鹽,抗憂鬱劑,Orexin拮抗劑,褪黑激素拮抗劑),各銷售管道,及市場區隔預測

Insomnia Therapeutics Market Analysis By Treatment Type [Devices, Drugs (Benzodiazepines, Nonbenzodiazepines, Antidepressants, Orexin Antagonists, Melatonin Antagonists)], By Sales Channel, And Segment Forecasts, 2014 - 2025

出版商 Grand View Research, Inc. 商品編碼 582040
出版日期 內容資訊 英文 101 Pages
商品交期: 2-3個工作天內
價格
Back to Top
失眠症治療藥市場分析:治療類別(設備,藥物:苯重氮基鹽,非苯重氮基鹽,抗憂鬱劑,Orexin拮抗劑,褪黑激素拮抗劑),各銷售管道,及市場區隔預測 Insomnia Therapeutics Market Analysis By Treatment Type [Devices, Drugs (Benzodiazepines, Nonbenzodiazepines, Antidepressants, Orexin Antagonists, Melatonin Antagonists)], By Sales Channel, And Segment Forecasts, 2014 - 2025
出版日期: 2017年10月24日內容資訊: 英文 101 Pages
簡介

本報告提供全球失眠症治療藥市場相關調查,彙整市場概要和各治療類別,各銷售管道,及各地區的趨勢,加入此市場的主要企業簡介等資料。

第1章 調查方法與調查範圍

第2章 摘要整理

第3章 市場變動,趨勢,範圍

  • 市場區隔和範圍
    • 推動市場的要素
    • 阻礙市場的要素
  • 滲透及成長預測製圖
  • SWOT分析
  • 產業分析:波特五力分析

第4章 治療類別預測與趨勢分析

  • 趨勢分析
  • 藥物
  • 設備

第5章 各銷售管道預測與趨勢分析

  • 趨勢分析
  • 處方
  • OTC

第6章 各地區預測與趨勢分析

  • 各地區市場佔有率
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲

第7章 競爭環境

  • 企業簡介
目錄
Product Code: GVR-2-68038-213-6

The global insomnia therapeutics market is expected to reach USD 3.45billion by 2025, according to a new report by Grand View Research, Inc. The market is primarily driven by thepresence of patented molecules, potential clinical pipeline candidates, rising stress level,and increase in geriatric population who find it difficult to fall asleep. Increase in prevalence of insomnia &awareness about this conditionand availability of safer drugs are anticipated to fuel revenue growth.

Insomnia is estimated to affect approximately 35% of the global population. Differentpatternsof the condition include difficulty in sleep initiation and maintenance, which is generally accompanied with frequent awakenings&awakening too early with trouble sleepingagain. Long-terminsomnia can hamper everyday life, which may result in nonproductive work hours. If left untreated, this conditionmay lead to severe depression and nervous breakdown of the patient.

Factors influencing insomnia therapeutics market growth includerising stress level, presence of patented molecules in the market, potentialdrugs in clinical pipeline, introduction of technologically advanced medical devices, and growinggeriatric population.Growing awareness about the impact of sleep deprivation on everyday lifeis anticipated to increaseadoption rate of various treatments for insomnia, which is expected to lead to revenue growth of the insomnia therapeutics market.

Currently, widely adopted treatment options for insomnia include generic nonbenzodiazepines and antidepressants even though other novel agents such as orexin antagonists and melatonin antagonists are available in the market.Launch of Eisai's Lemborexant is expected to cater to unmet medical needs in this segment and fuel growth of this market over the forecast period. According toUnited Nations (UN) report in 2015, population in the age group of 60 years and above is projected to grow by 56% and is expected to reach around 1.4 billion by 2030. These statistics indicate the growing geriatric population. Since this population base is more susceptible to sleep deprivation, the demand for insomnia therapeutics is anticipated to increase.

Further Key Findings From the Report Suggest:

North America held majority of the share in 2016 due to increase inawareness about diseases, growing geriatricpopulation, and high adoption of therapeutics for treatment.

The U.S. dominated North America owing to the presence of largest sleep-deprived population and use of patented drugs for treatment.

Japan is the second largest market after the U.S. Asia Pacific is expected to be the fastest growingmarket due to the presence ofemerging economies like China & India and launch of new drugs.

Some of the key players are Takeda Pharmaceutical Co. Ltd.; Vanda Pharmaceuticals; Merck & Co, Inc.;Pfizer Inc.; Teva Pharmaceutical Industries Ltd.; Mylan N. V.; Sumitomo Dainippon Pharma Co., Ltd.; Sanofi; Paratek Pharmaceuticals;and Ebb Therapeutics.

Table of Contents

Chapter 1 Research Methodology

  • 1.1 Information Procurement
    • 1.1.1 Purchased database:
    • 1.1.2 GVR's Internal Database
  • 1.2 Primary Research:
    • 1.2.1 List of primary sources include:

Chapter 2 Executive Summary

  • 2.1 Market Snapshot

Chapter 3 Insomnia Therapeutics Market Variables, Trends & Scope

  • 3.1 Market Segmentation & Scope
    • 3.1.1 Market driver analysis
      • 3.1.1.1 Technological advances in medical devices for insomnia.
      • 3.1.1.2 Presence of potential clinical pipeline candidates for insomnia.
      • 3.1.1.3 Rising stress levels and changing dynamics.
    • 3.1.2 Market restraint analysis
      • 3.1.2.1 Lower diagnosis rate, low treatment rate and high number of dis-satisfied patients.
      • 3.1.2.2 Declining revenues with the expiry of branded drugs.
  • 3.2 Insomnia Therapeutics Market - SWOT Analysis, by Factor (political & legal, economic and technological)
  • 3.3 Industry Analysis - Porter's

Chapter 4 Insomnia Therapeutics Market: Treatment Type Estimates & Trend Analysis

  • 4.1 Global Insomnia Therapeutics Market: Treatment Type Analysis
  • 4.2 Drugs
    • 4.2.1 Drugs treatment type market estimates and forecasts, 2014 - 2025 (USD Million)
  • 4.3 Devices
    • 4.3.1 Devices treatment type market estimates and forecasts, 2014 - 2025 (USD Million)

Chapter 5 Insomnia Therapeutics: Sales Channel Type Estimates & Trend Analysis

  • 5.1 Global Insomnia Therapeutics Market: Sales Channel Type Analysis
  • 5.2 Prescription
    • 5.2.1 Prescription sales channel segment market estimates and forecasts, 2014 - 2025 (USD Million)
  • 5.3 Over-the-Counter (OTC)
    • 5.3.1 Over-the-Counter (OTC) sales channel segment market estimates and forecasts, 2014 - 2025 (USD Million)

Chapter 6 Insomnia Therapeutics Market: Regional Estimates & Trend Analysis, by Treatment Type & Sales Channel

  • 6.1 Global Insomnia Therapeutics Market Share, by Region, 2015 & 2025
  • 6.2 North America
    • 6.2.1 Market estimates and forecasts, by treatment type 2014 - 2025 (USD Million)
    • 6.2.2 Market estimates and forecasts, by sales channel 2014 - 2025 (USD Million
    • 6.2.3 U.S.
      • 6.2.3.1 Market estimates and forecasts, by treatment type 2014 - 2025 (USD Million)
      • 6.2.3.2 Market estimates and forecasts, by sales channel 2014 - 2025 (USD Million)
    • 6.2.4 Canada
      • 6.2.4.1 Market estimates and forecasts, by treatment type 2014 - 2025 (USD Million)
      • 6.2.4.2 Market estimates and forecasts, by sales channel 2014 - 2025 (USD Million)
  • 6.3 Europe
    • 6.3.1 Market estimates and forecasts, by treatment type 2014 - 2025 (USD Million)
    • 6.3.2 Market estimates and forecasts, by sales channel 2014 - 2025 (USD Million)
    • 6.3.3 Germany
      • 6.3.3.1 Market estimates and forecasts, by treatment type 2014 - 2025 (USD Million)
      • 6.3.3.2 Market estimates and forecasts, by sales channel 2014 - 2025 (USD Million)
    • 6.3.4 UK
      • 6.3.4.1 Market estimates and forecasts, by treatment type 2014 - 2025 (USD Million)
      • 6.3.4.2 Market estimates and forecasts, by sales channel 2014 - 2025 (USD Million)
  • 6.4 Asia Pacific
    • 6.4.1 Market estimates and forecasts, by treatment type 2014 - 2025 (USD Million)
    • 6.4.2 Market estimates and forecasts, by sales channel 2014 - 2025 (USD Million)
    • 6.4.3 Japan
      • 6.4.3.1 Market estimates and forecasts, by treatment type 2014 - 2025 (USD Million)
      • 6.4.3.2 Market estimates and forecasts, by sales channel 2014 - 2025 (USD Million)
    • 6.4.4 China
      • 6.4.4.1 Market estimates and forecasts, by treatment type 2014 - 2025 (USD Million)
      • 6.4.4.2 Market estimates and forecasts, by sales channel 2014 - 2025 (USD Million)
  • 6.5 Latin America
    • 6.5.1 Market estimates and forecasts, by treatment type 2014 - 2025 (USD Million)
    • 6.5.2 Market estimates and forecasts, by sales channel 2014 - 2025 (USD Million)
    • 6.5.3 Brazil
      • 6.5.3.1 Market estimates and forecasts, by treatment type 2014 - 2025 (USD Million)
      • 6.5.3.1 Market estimates and forecasts, by sales channel 2014 - 2025 (USD Million)
    • 6.5.4 Mexico
      • 6.5.4.1 Market estimates and forecasts, by treatment type 2014 - 2025 (USD Million)
      • 6.5.4.2 Market estimates and forecasts, by sales channel 2014 - 2025 (USD Million)
  • 6.6 MEA
    • 6.6.1 Market estimates and forecasts, by treatment type 2014 - 2025 (USD Million)
    • 6.6.2 Market estimates and forecasts, by sales channel 2014 - 2025 (USD Million)
    • 6.6.3 South Africa
      • 6.2.3.1 Market estimates and forecasts, by treatment type 2014 - 2025 (USD Million)
      • 6.2.3.2 Market estimates and forecasts, by sales channel 2014 - 2025 (USD Million)

Chapter 7 Competitive Landscape

  • 7.1 Company Profiles
    • 7.1.1 Takeda Pharmaceutical Company Ltd.
      • 7.1.1.1 Company overview
      • 7.1.1.2 Financial performance
      • 7.1.1.3 Product Benchmarking
      • 7.1.1.4 Strategic initiatives
    • 7.1.2 Vanda Pharmaceuticals Inc.
      • 7.1.2.1 Company overview
      • 7.1.2.2 Financial performance
      • 7.1.2.3 Product benchmarking
      • 7.1.2.4 Strategic initiatives
    • 7.1.3 Merck & Co.
      • 7.1.3.1 Company overview
      • 7.1.3.2 Financial performance
      • 7.1.3.3 Product Benchmarking
      • 7.1.3.4 Strategic initiatives
    • 7.1.4 Mylan N.V.
      • 7.1.4.1 Company overview
      • 7.1.4.2 Financial performance
      • 7.1.4.3 Product Benchmarking
      • 7.1.4.4 Strategic initiatives
    • 7.1.5 Pfizer Inc.
      • 7.1.5.1 Company overview
      • 7.1.5.2 Financial performance
      • 7.1.5.3 Product Benchmarking
      • 7.1.5.4 Strategic initiatives
    • 7.1.6 Teva Pharmaceutical Industries Ltd.
      • 7.1.6.1 Company overview
      • 7.1.6.2 Financial performance
      • 7.1.6.3 Product Benchmarking
      • 7.1.6.4 Strategic initiatives
    • 7.1.7 Sumitomo Dainippon Pharma Co., Ltd.
      • 7.1.7.1 Company overview
      • 7.1.7.2 Financial performance
      • 7.1.7.3 Product Benchmarking
      • 7.1.7.4 Strategic initiatives
    • 7.1.8 Sanofi S.A.
      • 7.1.8.1 Company overview
      • 7.1.8.2 Financial performance
      • 7.1.8.3 Product Benchmarking
      • 7.1.8.4 Strategic initiatives
    • 7.1.9 Paratek Pharmaceuticals, Inc.
      • 7.1.9.1 Company overview
      • 7.1.9.2 Financial performance
      • 7.1.9.3 Product Benchmarking
      • 7.1.9.4 Strategic initiatives
    • 7.1.10 Ebb Therapeutics.
      • 7.1.10.1 Company overview
      • 7.1.10.2 Product Benchmarking
      • 7.1.10.3 Strategic initiatives

List of Tables

  • TABLE 1 Global insomnia therapeutics market estimates and forecast by treatment type, 2014 - 2025 (USD Million)
  • TABLE 2 Global insomnia therapeutics market estimates and forecast by sales channel, 2014 - 2025 (USD Million)
  • TABLE 3 North America insomnia therapeutics market estimates and forecast by treatment type, 2014 - 2025 (USD Million)
  • TABLE 4 North America insomnia therapeutics market estimates and forecast by sales channel, 2014 - 2025 (USD Million)
  • TABLE 5 U.S. insomnia therapeutics market estimates and forecast by treatment type, 2014 - 2025 (USD Million)
  • TABLE 6 U.S. insomnia therapeutics market estimates and forecast by sales channel, 2014 - 2025 (USD Million)
  • TABLE 7 Canada insomnia therapeutics market estimates and forecast by treatment type, 2014 - 2025 (USD Million)
  • TABLE 8 Canada insomnia therapeutics market estimates and forecast by sales channel, 2014 - 2025 (USD Million)
  • TABLE 9 Latin America insomnia therapeutics market estimates and forecast by treatment type, 2014 - 2025 (USD Million)
  • TABLE 10 Latin America insomnia therapeutics market estimates and forecast by sales channel, 2014 - 2025 (USD Million)
  • TABLE 11 Mexico insomnia therapeutics market estimates and forecast by treatment type, 2014 - 2025 (USD Million)
  • TABLE 12 Mexico insomnia therapeutics market estimates and forecast by sales channel, 2014 - 2025 (USD Million)
  • TABLE 13 Brazil insomnia therapeutics market estimates and forecast by treatment type, 2014 - 2025 (USD Million)
  • TABLE 14 Brazil insomnia therapeutics market estimates and forecast by sales channel, 2014 - 2025 (USD Million)
  • TABLE 15 Europe insomnia therapeutics market estimates and forecast by treatment type, 2014 - 2025 (USD Million)
  • TABLE 16 Europe insomnia therapeutics market estimates and forecast by sales channel, 2014 - 2025 (USD Million)
  • TABLE 17 U.K. insomnia therapeutics market estimates and forecast by treatment type, 2014 - 2025 (USD Million)
  • TABLE 18 U.K. insomnia therapeutics market estimates and forecast by sales channel, 2014 - 2025 (USD Million)
  • TABLE 19 Germany insomnia therapeutics market estimates and forecast by treatment type, 2014 - 2025 (USD Million)
  • TABLE 20 Germany insomnia therapeutics market estimates and forecast by sales channel, 2014 - 2025 (USD Million)
  • TABLE 21 Asia Pacific insomnia therapeutics market estimates and forecast by treatment type, 2014 - 2025 (USD Million)
  • TABLE 22 Asia Pacific insomnia therapeutics market estimates and forecast by sales channel, 2014 - 2025 (USD Million)
  • TABLE 23 Japan insomnia therapeutics market estimates and forecast by treatment type, 2014 - 2025 (USD Million)
  • TABLE 24 Japan insomnia therapeutics market estimates and forecast by application, 2014 - 2025 (USD Million)
  • TABLE 25 China insomnia therapeutics market estimates and forecast by treatment type, 2014 - 2025 (USD Million)
  • TABLE 26 China insomnia therapeutics market estimates and forecast by sales channel, 2014 - 2025 (USD Million)
  • TABLE 27 MEA insomnia therapeutics market estimates and forecast by treatment type, 2014 - 2025 (USD Million)
  • TABLE 28 MEA insomnia therapeutics market estimates and forecast by sales channel, 2014 - 2025 (USD Million)
  • TABLE 29 South Africa insomnia therapeutics market estimates and forecast by treatment type, 2014 - 2025 (USD Million)
  • TABLE 30 South Africa insomnia therapeutics market estimates and forecast by sales channel, 2014 - 2025 (USD Million)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information procurement
  • FIG. 3 Primary research pattern
  • FIG. 4 Market summary
  • FIG. 5 Market trends & outlook
  • FIG. 6 Market segmentation & scope
  • FIG. 7 Market driver relevance analysis (Current & future impact)
  • FIG. 8 Market restraint relevance analysis (Current & future impact)
  • FIG. 9 Key opportunity priorities
  • FIG. 10 SWOT analysis, by factor (political & legal, economic and technological)
  • FIG. 11 Porter's Five Forces Analysis
  • FIG. 12 Global insomnia therapeutics market, Heat map analysis
  • FIG. 13 Global insomnia therapeutics market treatment type outlook & key takeaways
  • FIG. 14 Global insomnia therapeutics market drugs segment outlook & key takeaways
  • FIG. 15 Global insomnia therapeutics market devices segment outlook & key takeaways
  • FIG. 16 Global insomnia therapeutics market: sales channel type outlook & key takeaways
  • FIG. 17 Global insomnia therapeutics market, regional outlook & key takeaways 2014 - 2025
  • FIG. 18 North America insomnia therapeutics estimates and forecasts, 2014 - 2025 (USD Million)
  • FIG. 19 U.S. insomnia therapeutics market estimates and forecasts, 2014 - 2025 (USD Million)
  • FIG. 20 Canada insomnia therapeutics market estimates and forecasts, 2014 - 2025 (USD Million)
  • FIG. 21 Europe insomnia therapeutics market estimates and forecasts, 2014 - 2025 (USD Million)
  • FIG. 22 Germany insomnia therapeutics market estimates and forecasts, 2014 - 2025 (USD Million)
  • FIG. 23 U.K. insomnia therapeutics estimates and forecasts, 2014 - 2025 (USD Million)
  • FIG. 24 Asia Pacific insomnia therapeutics market estimates and forecasts, 2014 - 2025 (USD Million)
  • FIG. 25 China insomnia therapeutics market estimates and forecasts, 2014 - 2025 (USD Million)
  • FIG. 26 Japan insomnia therapeutics market estimates and forecasts, 2014 - 2025 (USD Million)
  • FIG. 27 Latin America insomnia therapeutics market estimates and forecasts, 2014 - 2025 (USD Million)
  • FIG. 28 Brazil insomnia therapeutics market estimates and forecasts, 2014 - 2025 (USD Million)
  • FIG. 29 Mexico insomnia therapeutics market estimates and forecasts, 2014 - 2025 (USD Million)
  • FIG. 30 MEA insomnia therapeutics market estimates and forecasts, 2014 - 2025 (USD Million)
  • FIG. 31 South Africa insomnia therapeutics market estimates and forecasts, 2014 - 2025 (USD Million)
Back to Top